Lethargy

Greater Good Charities and Boehringer Ingelheim Kick Off Fourth Year of Good Flights Program and Celebrate Successful Transport of More Than 12,800 Shelter Pets to Adoptive Homes Including Nearly 1,300 Asymptomatic Heartworm-Positive Dogs

Retrieved on: 
Monday, April 8, 2024
DSM-IV codes, PLUS, Transport, Disease, Moxidectin, Seizure, Boehringer Ingelheim, Tablet, Diarrhea, Life, House, Dog, Lethargy, Euthanasia, Greater good, Coccidioides immitis, Safety, Terrebonne Parish, Louisiana, Good, Hookworm, Pet, Cat, Atmosphere of Earth, Itch, Animal rescue, Vomiting, Flea, Heart, Boehringer Ingelheim Animal Health, Pharmaceutical industry

To kick off the fourth year of Good Flights, a special transport of more than 45 shelter pets will take place on April 8 from Louisiana to the East Coast.

Key Points: 
  • To kick off the fourth year of Good Flights, a special transport of more than 45 shelter pets will take place on April 8 from Louisiana to the East Coast.
  • Air and ground transports for Good Flights occur approximately five times a month and many have Save a Heart pets on them.
  • “The Good Flights Program and Save a Heart initiative represents a remarkable collaboration between Greater Good Charities and Boehringer Ingelheim,” said Dr. Julie Ryan-Johnson, Senior Associate Director - Shelter Engagement Program, Boehringer Ingelheim.
  • Good Flights covers transport costs, provides mentorship, pharmaceuticals, and furnishes much needed supplies including pet crates, bowls, and leashes.

Quectel unveils its HCM511S high performance MCU Bluetooth module to power Low Energy compact connected devices

Retrieved on: 
Tuesday, April 9, 2024
Hardware, IOT (Internet of Things), Building Systems, Semiconductor, Security, Construction & Property, Consumer Electronics, Technology, Audio, Video, Apps, Applications, Wearables, Mobile Technology, Telecommunications, Software, Networks, Mobile, Wireless, Cortex, Blood pressure, Temperature, PC, USART, Sport, Internet of things, SPI, Bluetooth Special Interest Group, Embedded, Secure, ARM, Bluetooth mesh networking, LCC, Engineering, PWM, RAM, VEX, Thermometer, I2S, CSO, Multimedia, ADC, Lethargy, Bluetooth

Embedded World – Quectel Wireless Solutions, a global IoT solutions provider, is pleased to announce the launch of the HCM511S high-performance MCU Bluetooth module for compact connected devices such as digital keys, portable devices and battery-operated motion sensors.

Key Points: 
  • Embedded World – Quectel Wireless Solutions, a global IoT solutions provider, is pleased to announce the launch of the HCM511S high-performance MCU Bluetooth module for compact connected devices such as digital keys, portable devices and battery-operated motion sensors.
  • Utilizing Bluetooth Low Energy 5.4, the module accommodates an ARM Cortex-M33 processor and features built-in 32KB RAM and either 352KB or 512KB flash memory to deliver efficient performance.
  • View the full release here: https://www.businesswire.com/news/home/20240409992885/en/
    Quectel unveils its HCM511S high performance MCU Bluetooth module to power Low Energy compact connected devices (Graphic: Business Wire)
    The HCM511S module features excellent receiver sensitivity, a maximum transmit power of +6 dBm to achieve long distance transmission and has been designed to enable compact, low-power devices to connect cost effectively.
  • “We’re delighted to bring the compact, high-performance HCM511S Bluetooth Low Energy MCU module to the market,” says Norbert Muhrer, President and CSO, Quectel Wireless Solutions.

Alif Semiconductor Announces World's First BLE and Matter Wireless Microcontroller to Feature Neural Co-Processor for AI/ML Workloads

Retrieved on: 
Tuesday, April 9, 2024
Cortex, Arm, LPA, BLE, Machine learning, Logic, LC3, Algorithm, DSP, HPA, WLCSP, Acceleration, Memory, Business, ARM Cortex-M, MCU, AI accelerator, Bluetooth Low Energy, Spacecraft, Senior, TWS, Architecture, Radio, DAC, NPU, TCM, GOPS, Family, MVE, Artificial intelligence, EEMBC, Lethargy, Video game

PLEASANTON, Calif., April 9, 2024 /PRNewswire/ -- Alif Semiconductor®, a leading global supplier of secure, connected, power efficient Artificial Intelligence and Machine Learning (AI/ML) microcontrollers (MCUs) and fusion processors, today announced the launch of the BallettoTM family, the world's first Bluetooth® Low Energy (BLE) wireless microcontroller to feature hardware optimization for AI/ML workloads.

Key Points: 
  • The Balletto family offers particularly strong performance in audio and sensor functions thanks to its excellent DSP and AI/ML capabilities and large on-die memory.
  • Neural network processing performance is up to 15x better than a Cortex-M4 processor can achieve.
  • Balletto includes the state-of-the-art multi-layered security fabric first introduced in Alif Semiconductors' Ensemble family of MCUs and fusion processors.
  • "Alif Semiconductor's Balletto family is targeting BLE challenges faced by the wireless audio and smart home industry today with a platform adapted to high bit-rate audio and the Matter ecosystem," said Reza Kazerounian, President and Co-Founder of Alif Semiconductor.

Alif Semiconductor Announces World's First BLE and Matter Wireless Microcontroller to Feature Neural Co-Processor for AI/ML Workloads

Retrieved on: 
Tuesday, April 9, 2024
Cortex, Arm, LPA, BLE, Machine learning, Logic, LC3, Algorithm, DSP, HPA, WLCSP, Acceleration, Memory, Business, ARM Cortex-M, MCU, AI accelerator, Bluetooth Low Energy, Spacecraft, Senior, TWS, Architecture, Radio, DAC, NPU, TCM, GOPS, Family, MVE, Artificial intelligence, EEMBC, Lethargy, Video game

PLEASANTON, Calif., April 9, 2024 /PRNewswire/ -- Alif Semiconductor®, a leading global supplier of secure, connected, power efficient Artificial Intelligence and Machine Learning (AI/ML) microcontrollers (MCUs) and fusion processors, today announced the launch of the BallettoTM family, the world's first Bluetooth® Low Energy (BLE) wireless microcontroller to feature hardware optimization for AI/ML workloads.

Key Points: 
  • The Balletto family offers particularly strong performance in audio and sensor functions thanks to its excellent DSP and AI/ML capabilities and large on-die memory.
  • Neural network processing performance is up to 15x better than a Cortex-M4 processor can achieve.
  • Balletto includes the state-of-the-art multi-layered security fabric first introduced in Alif Semiconductors' Ensemble family of MCUs and fusion processors.
  • "Alif Semiconductor's Balletto family is targeting BLE challenges faced by the wireless audio and smart home industry today with a platform adapted to high bit-rate audio and the Matter ecosystem," said Reza Kazerounian, President and Co-Founder of Alif Semiconductor.

Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®

Retrieved on: 
Tuesday, March 26, 2024
Ulcer, Myocardial infarction, Liver disease, Endo International, Hyperkalemia, Horizon Therapeutics, Patient, Stroke, History, Aspirin, CABG, Pain, Famotidine, Itch, NSAID, Stomach, Central nervous system, Edema, ACE, Risk, CNS, Perforation, Peptic ulcer disease, Heart failure, Anaphylaxis, Amgen, Fatigue, Hypertension, Delirium, Kidney, Coma, Tablet, Eosinophilia, Nonsteroidal anti-inflammatory drug, Senior, Rash, Lethargy, OTC, Creatinine, Hepatotoxicity, Ibuprofen, Hypersensitivity, Esophagus, Jaundice, Rheumatoid arthritis, Water retention, Seizure, Incidence, Gastrointestinal bleeding, Inflammation, Extrapyramidal system, Ischemia, Diarrhea, GI, Nausea, Diuretic, Bleeding, NSAIDS, Physician, Osteoarthritis, Pharmaceutical industry

DUBLIN, March 26, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., launched ibuprofen-famotidine 800 mg/26.6 mg tablets, a generic version of Amgen's (formerly Horizon Therapeutics) DUEXIS®.

Key Points: 
  • DUBLIN, March 26, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., launched ibuprofen-famotidine 800 mg/26.6 mg tablets, a generic version of Amgen's (formerly Horizon Therapeutics) DUEXIS®.
  • Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at a greater risk for serious GI events.
  • Ibuprofen and famotidine tablets should not be administered to patients with a history of hypersensitivity to other H2-receptor antagonists.
  • If ibuprofen and famotidine is used in patients with a recent MI, monitor patients for signs of cardiac ischemia.

Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®

Retrieved on: 
Tuesday, March 26, 2024
Ulcer, Myocardial infarction, Liver disease, Endo International, Hyperkalemia, Horizon Therapeutics, Patient, Stroke, History, Aspirin, CABG, Pain, Famotidine, Itch, NSAID, Stomach, Central nervous system, Edema, ACE, Risk, CNS, Perforation, Peptic ulcer disease, Heart failure, Anaphylaxis, Amgen, Fatigue, Hypertension, Delirium, Kidney, Coma, Tablet, Eosinophilia, Nonsteroidal anti-inflammatory drug, Senior, Rash, Lethargy, OTC, Creatinine, Hepatotoxicity, Ibuprofen, Hypersensitivity, Esophagus, Jaundice, Rheumatoid arthritis, Water retention, Seizure, Incidence, Gastrointestinal bleeding, Inflammation, Extrapyramidal system, Ischemia, Diarrhea, GI, Nausea, Diuretic, Bleeding, NSAIDS, Physician, Osteoarthritis, Pharmaceutical industry

DUBLIN, March 26, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., launched ibuprofen-famotidine 800 mg/26.6 mg tablets, a generic version of Amgen's (formerly Horizon Therapeutics) DUEXIS®.

Key Points: 
  • DUBLIN, March 26, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., launched ibuprofen-famotidine 800 mg/26.6 mg tablets, a generic version of Amgen's (formerly Horizon Therapeutics) DUEXIS®.
  • Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at a greater risk for serious GI events.
  • Ibuprofen and famotidine tablets should not be administered to patients with a history of hypersensitivity to other H2-receptor antagonists.
  • If ibuprofen and famotidine is used in patients with a recent MI, monitor patients for signs of cardiac ischemia.

1.9 Million Doses of NexGard® PLUS (afoxolaner, moxidectin and pyrantel chewable tablets): Donated by Boehringer Ingelheim Cares Foundation to Aid Shelter Dogs in Need

Retrieved on: 
Friday, March 15, 2024
Parasitism, Health, DSM-IV codes, Moxidectin, Coccidioides immitis, Boehringer Ingelheim, Tablet, Tick, Diarrhea, Dog, Lethargy, Boehringer, Breeding, Pet, Vomiting, Animal, Pharmaceutical industry

The Boehringer Ingelheim Cares Foundation has donated 1.9 million doses of NexGard® PLUS to animal shelters in need.

Key Points: 
  • The Boehringer Ingelheim Cares Foundation has donated 1.9 million doses of NexGard® PLUS to animal shelters in need.
  • The Foundation has donated 1.9 million doses of NexGard® PLUS chews, a delicious beef-flavored soft chew, designed to protect dogs from fleas and ticks, prevent heartworm disease, and treat and control roundworms and hookworms.
  • Over 6 million doses of NexGard® PLUS chews have been sold since its launch in 2023.
  • NexGard® PLUS (afoxolaner, moxidectin, and pyrantel chewable tablets) are for use in dogs only.

TI to showcase technologies for a safer, smarter and more sustainable future at embedded world 2024

Retrieved on: 
Wednesday, March 13, 2024
Cortex, Arm, Smartphone, TI, Heat, Memory, Ventilation, Robotics, AI, Software, Amazon Robotics, Texas Instruments, AMR, Proteus, HVAC, MRSC, HMI, PFC, Lethargy

DALLAS, March 13, 2024 /PRNewswire/ -- Texas Instruments (TI) (Nasdaq: TXN) today announced that it will demonstrate new embedded processing and connectivity products for enabling a safer, smarter and more sustainable future at embedded world, April 9 through 11 in Nuremberg, Germany.

Key Points: 
  • DALLAS, March 13, 2024 /PRNewswire/ -- Texas Instruments (TI) (Nasdaq: TXN) today announced that it will demonstrate new embedded processing and connectivity products for enabling a safer, smarter and more sustainable future at embedded world, April 9 through 11 in Nuremberg, Germany.
  • "Advancements in embedded processing are redefining the potential of industrial and automotive applications around the world," said Amichai Ron, senior vice president, TI Embedded Processing.
  • TI will showcase how its innovative semiconductors, intuitive software and design expertise can help developers transform designs to make them smarter, safer and more adaptive.
  • Additionally, TI will display embedded technologies and reference designs for perceptive sensing, precise motor control, real-time communication and AI capabilities.

AiRISTA Named a Leader in 2024 Gartner® Magic Quadrant™ for Indoor Location Services

Retrieved on: 
Monday, March 11, 2024
Cloud, RFID, BLE, Wi-Fi, Internet, Research, Organization, Publication, Investment, Magic Quadrant, RTLS, Lethargy

SPARKS, Md., March 11, 2024 /PRNewswire/ -- AiRISTA, a global leader in real time location services (RTLS), today announced that it has been recognized by Gartner, Inc. as a "Leader" in the 2024 Magic Quadrant for Indoor Location Services. This is the third consecutive year AiRISTA has been recognized in the Leaders Quadrant. Click here for a copy of the full report.

Key Points: 
  • SPARKS, Md., March 11, 2024 /PRNewswire/ -- AiRISTA , a global leader in real time location services (RTLS), today announced that it has been recognized by Gartner, Inc. as a "Leader" in the 2024 Magic Quadrant for Indoor Location Services.
  • "AiRISTA is honored to be recognized for a third consecutive year by Gartner as a Leader in the 2024 Magic Quadrant for Indoor Location Services," said Sy Sajjad, CEO and founder of AiRISTA.
  • We believe AiRISTA and its sofia RTLS platform is a dominant indoor location services platform, offered on-premises or in cloud as sofia Cloud platform.
  • AiRISTA is recognized as a Leader in the Gartner Magic Quadrant for Indoor Location Services report for a third consecutive year.

Epic Passes Now On Sale for the 2024/25 Winter Season; Lock in the Lowest Price to Legendary Resorts Like Vail Mountain, Whistler Blackcomb, Park City Mountain, Breckenridge and More

Retrieved on: 
Tuesday, March 5, 2024
Cream, Condition, Investment, Telluride Ski Resort, Policy, Military, Epic, Veteran, Privacy, Canadian Armed Forces, Alpine, Pass, Woman, Australian Defence Force, Use, Perisher, Acquisition, Friends, Golf, Food, RFID, Mountain resort, Keystone Resort, Lethargy, Amusement park

With additional partner resorts like Telluride, the Epic Pass unlocks access to more than 80 resorts.

Key Points: 
  • With additional partner resorts like Telluride, the Epic Pass unlocks access to more than 80 resorts.
  • Offered ahead of the season, Epic Day Passes provide savings up to 65% compared to lift ticket prices.
  • Provides unlimited, unrestricted access to 42* resorts – including Vail Mountain, Beaver Creek Mountain Resort, Breckenridge Mountain, Keystone Resort, Park City Mountain, Whistler Blackcomb, as well as Andermatt-Sedrun-Disentis and Crans-Montana Mountain Resort* in Switzerland.
  • Epic Pass plans to provide access to Switzerland's Crans-Montana Mountain Resort: Vail Resorts plans to provide Pass Holders access to another international resort in the 2024/25 winter season.